Galmed Pharmaceuticals Ltd. buy Barclays PLC
Start price
09.05.24
/
50%
€0.40
Target price
09.05.25
€78.88
Performance (%)
-15.15%
Price
04.06.24
€0.34
Summary
This prediction is currently active. The price of Galmed Pharmaceuticals Ltd. has decreased since the start of the prediction. Compared to the start price this results in a performance of -15.15%. This prediction currently runs until 09.05.25. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Galmed Pharmaceuticals Ltd. | 0.000% |
iShares Core DAX® | 0.597% |
iShares Nasdaq 100 | 0.899% |
iShares Nikkei 225® | 1.775% |
iShares S&P 500 | 0.990% |
Comments by Barclays_PLC for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at Barclays PLC from $83.00 to $85.00. They now have an "overweight" rating on the stock.
Ratings data for GMED provided by MarketBeat